Thank you for sharing!

Your article was successfully shared with the contacts you provided.

(To read more on the multifamily market, click here.)

CAMBRIDGE, MA-Kendall Square will soon have another luxury apartment and condominium community amid its biotech core. Joint partners Extell Development Co. of New York and Chicago-based Equity Residential have broken ground on a 531-unit, $225 million complex at 303 Third St. The apartment building will be located across the street from biotech giant Genzyme Corp.’s headquarters.

Plans call for the construction of two buildings, with 292 apartments in one and 239 condominiums in the other. Each building will have ground level retail separated by a one-acre courtyard.

The project, which is not yet named, is set to be completed in 2008, says Chris Reilly, area vice president for Equity Residential. The complex is the third in the Boston area under development by Equity. In June, the company broke ground on a a five-building, $160-million, 310-unit property near the banks of the Charles River called the Equity Residential Development at Emerson Place. That development is the first along the Charles River in 25 years, Reilly says. Equity also is building 120 units of senior housing in Westwood.

Extell, the developer of the Intercontinental Boston, could not be reached for comment.

Equity and Extell’s latest Cambridge venture, designed by New York architect Centra/Ruddy, is just the latest in a string of residential buildings popping up around Kendall Square. The area has been long-known as a high tech epicenter because of its proximity to the Massachusetts Institute of Technology and Harvard Square. The location of those schools along with hundreds of nearby offices, a rapid transit stop and a city master plan that calls for the creation of a theater complex in the area, makese Kendall Square one of the hottest development sites in Cambridge.

Watermark residences, a 24-story, 321-unit luxury tower located across the street from the Equity and Extell venture, was completed earlier this year by Twining Properties, of New York, at a cost of about $100 million. Twining also is planning a 20-story tower with 123 residences costing $70 million as part of Watermark’s second phase.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


GlobeSt. Multifamily Spring 2022 (Formerly APTS)Event

Join 1000+ of the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!

Get More Information


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt
Live Chat

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.